摘要 |
<p>A compound of formula (I) and salts thereof are provided: wherein A is defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.</p> |
申请人 |
GLAXO GROUP LIMITED;BRADLEY, DANIEL, MARCUS;CHAN, WAI, NGOR;HARRISON, STEPHEN, ANTHONY;THEWLIS, KEVIN, MICHAEL;WARD, SIMON, EDWARD |
发明人 |
BRADLEY, DANIEL, MARCUS;CHAN, WAI, NGOR;HARRISON, STEPHEN, ANTHONY;THEWLIS, KEVIN, MICHAEL;WARD, SIMON, EDWARD |